Skip to main content
CNCCentene CorporationSell5.2·$66.21+1.81%
Open full analysis

Centene Corporation (CNC) Stock Analysis

Breakout setup

SellModerate Confidence

Healthcare · Healthcare Plans

Sell if holding. Engine safety override at $66.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality.

Centene is the largest U.S. managed care company focused on underserved populations, with $194.8 billion in 2025 revenues and 27.6 million members. It is the largest Medicaid insurer (12.5M members in 30 states), largest ACA Marketplace carrier (5.5M members), and largest... Read more

$66.21-1.5% A.UpsideScore 5.2/10#7 of 11 Healthcare Plans
QualityF-score6 / 9FCF yield21.32%
Stop $61.81Target $65.22(resistance)A.R:R -1.2:1
Analyst target$60.59-8.5%17 analysts
$65.22our TP
$66.21price
$60.59mean
$40
$80

Sell if holding. Engine safety override at $66.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Score 5.2/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, news boost analyst 0.60, news boost analyst cluster(3), earnings proximity 49d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-10

Recent Developments — Centene Corporation

Generated 2026-06-15T18:11:46Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Jul 28, 202649d to earnings· next earnings call

Thesis

Rewards
Recent Analyst detected in news
Recent Analyst Cluster(3) detected in news
Risks
Concentration risk — Product: Medicaid (57.0%)
Target reached (-17.6% upside)
Quality below floor (2.3 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)14.6
Mkt Cap$32.1B
EV/EBITDA8.6
Profit Mgn-3.6%
ROE-26.0%
Rev Growth5.1%
Beta1.09
DividendNone
Rating analysts26

Quality Signals

Piotroski F6/9

Options Flow

P/C1.05bearish
IV50%elevated

Concentration Risks(10-K Item 1A)

  • HIGHProductMedicaid57%
    10-K Item 1: 'our Medicaid, Commercial, Medicare and Other segments accounted for 57%, 21%, 19% and 3%, respectively, of our total external revenues'
  • MEDIUMGeographicFlorida and New York Medicaid contracts
    10-K Item 1: 'Our Medicaid contracts with the states of Florida and New York accounted for approximately 10% or more of our consolidated Medicaid premium revenues individually'

Material Events(8-K, last 90d)

  • 2026-03-24Item 5.02LOW
    Theodore Pienkos appointed Corporate Controller and Chief Accounting Officer effective March 18, 2026. Previously Deputy Corporate Controller since August 2024. Base salary $440K, 60% target bonus. No predecessor departure cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Unprofitable operations — net margin -3.6%. Quality floor flags this regardless of sector context.static

Roe
0.0
Gross Margin
0.0
Net Margin
0.0
Roa
0.8
Operating Margin
2.0
Current Ratio
4.4
Moat
4.4
Piotroski F
6.7
No competitive moatQuality concerns

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.3
52w Position
9.9
GatesA.R:R -1.2=NEGATIVEExecutive change: officer departure/appointmentMomentum 7.1>=5.5Insider activity: OKNEWS BOOST ANALYST 0.60NEWS BOOST ANALYST CLUSTER(3)EARNINGS PROXIMITY 49d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
68 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $55.78Resistance $66.55

Price Targets

$62
$65
A.Upside-1.5%
A.R:R-1.2:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-17.6% upside)
! Quality below floor (2.3 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-28 (49d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CNC stock a buy right now?

Sell if holding. Engine safety override at $66.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 68, MACD bullish. Prior stop was $61.81. Score 5.2/10, moderate confidence.

What is the CNC stock price target?

Take-profit target: $65.22 (-1.5% upside). Prior stop was $61.81. Stop-loss: $61.81.

What are the risks of investing in CNC?

Concentration risk — Product: Medicaid (57.0%); Target reached (-17.6% upside); Quality below floor (2.3 < 4.0).

Is CNC overvalued or undervalued?

Centene Corporation trades at a P/E of N/A (forward 14.6). TrendMatrix value score: 6.8/10. Verdict: Sell.

What do analysts say about CNC?

26 analysts cover CNC with a consensus score of 3.5/5. Average price target: $61.

What does Centene Corporation do?Centene is the largest U.S. managed care company focused on underserved populations, with $194.8 billion in 2025...

Centene is the largest U.S. managed care company focused on underserved populations, with $194.8 billion in 2025 revenues and 27.6 million members. It is the largest Medicaid insurer (12.5M members in 30 states), largest ACA Marketplace carrier (5.5M members), and largest stand-alone PDP provider (8.1M members).

Related stocks: CI (The Cigna Group) · OSCR (Oscar Health, Inc.) · CVS (CVS Health Corporation) · HUM (Humana Inc.) · ELV (Elevance Health, Inc.)
Home Stocks CNC

Latest news

Latest News

Benzinga7d agoAnalyst
Benzinga7d agoAnalyst
Benzinga11d agoAnalyst
Benzinga11d agoAnalyst
Benzinga14d agoAnalyst
Benzinga24d ago
Benzinga24d ago
Benzinga24d agoAnalyst
Benzinga26d agoAnalyst
Benzinga26d agoAnalyst
Benzinga34d ago
Benzinga42d agoAnalyst
Benzinga43d ago
Benzinga45d ago
Benzinga45d agoAnalyst
Benzinga46d ago
Benzinga46d agoAnalyst
Benzinga46d ago
Benzinga47d agoAnalyst
Benzinga47d ago
Loading more...